For instance, Scherer and coworkers recently developed and characterized an immune-humanized PDX model of estrogen-independent endocrine-resistant ER-positive metastatic BC that harbors a naturally occurring ESR1 mutation (126). Here, ESR1 is linked to breast cancer.